Best known as a type 2 diabetes treatment, metformin is also being investigated for its possible effects on PCOS and ageing.

A major clinical trial has found that real-time continuous glucose monitoring (CGM) significantly improves blood glucose ...

A new fiber probe developed by researchers at The University of Texas at Austin delivers two major innovations in health ...

Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...

In 1999, the U.S. Food and Drug Administration approved continuous glucose monitoring (CGM), a medical device that uses a ...

The early recognition of type 1 diabetes in a toddler with increased thirst, lethargy, vision difficulties, and fruity breath ...

On social media, people without diabetes have started tracking their blood sugar and posting about the harms of blood sugar ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Cash position of €17.2m as of December 31, 2025Progresses achieved with our flagship projects in 2025:Chinese partner Tonghua Dongbao completed BioChaperone® Lispro Phase 3 program with positive ...

Glucotrack (Nasdaq:GCTK) today announced the publication of a peer-reviewed scientific article evaluating its long-term ...

Senseonics VP of Product Development Hari Sree explains the tech behind the Eversense 365-day CGM and what's next in the ...